期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of hepatoma H22 on lymphatic endothelium in vitro 被引量:3
1
作者 HuaYu hong-zhizhou +2 位作者 Chun-MeiWang Xiao-MingGu Bo-RongPan 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第23期3428-3432,共5页
AIM: To determine the effect of metastatic hepatoma cells on lymphangioma-derived endothelium, and to establish in vitro model systems for assessing metastasis-related response of lymphatic endothelium.METHODS: Benign... AIM: To determine the effect of metastatic hepatoma cells on lymphangioma-derived endothelium, and to establish in vitro model systems for assessing metastasis-related response of lymphatic endothelium.METHODS: Benign lymphangioma, induced by intraperitoneal injection of the incomplete Freund's adjuvant in BALB/c mice, was embedded in fibrin gel or digested and then cultured in the conditioned medium derived from hepatoma H22. Ught and electron microscopy, and the b-answell migration assay were used to determine the effect of H22 on tissue or cell culture. Expressions of Fit-4, c-Fos, proliferating cell nuclear antigen (PCNA), and inducible nitric oxide synthase (iNOS) in cultured cells, and content of nitric oxide in culture medium were also examined.RESULTS: The embedded lymphangioma pieces gave rise to array of capillaries, while separated cells from lymphangioma grew to a cobblestone-like monolayer. H22 activated growth and migration of the capillaries and cells, induced expressions of Flt-4, c-Fos, PCNA and iNOS in cultured cells, and significantly increased the content of NO in the culture medium.CONCLUSION: Lymphangioma-derived cells keep the differentiated phenotypes of lymphatic endothelium, and the models established in this study are feasible for in vitro study of metastasis-related response of lymphatic endothelium. 展开更多
关键词 肝细胞H22 淋巴腺 内皮细胞 淋巴管瘤 肿瘤
下载PDF
嗜铬粒蛋白A和突触素的动态变化对胰腺神经内分泌肿瘤患者术后的效果评价 被引量:1
2
作者 武宏 李志周 +1 位作者 陈锋 刘伟 《国际外科学杂志》 2017年第7期476-479,共4页
目的研究胰腺神经内分泌肿瘤患者行腹腔镜手术治疗后的嗜铬粒蛋白A和突触素的动态变化,为患者的确诊及预后情况进行监控。方法选取2013年3月-2015年3月榆林市第一医院收治的45例胰腺神经内分泌肿瘤患者为对象,所有患者均给予腹腔镜手... 目的研究胰腺神经内分泌肿瘤患者行腹腔镜手术治疗后的嗜铬粒蛋白A和突触素的动态变化,为患者的确诊及预后情况进行监控。方法选取2013年3月-2015年3月榆林市第一医院收治的45例胰腺神经内分泌肿瘤患者为对象,所有患者均给予腹腔镜手术治疗,观察手术效果并监测患者术后嗜铬粒蛋白A和突触素的水平。组间比较采用,检验。所有患者均通过电话随访,随访日期截至2017年1月。结果TNM分期良性患者与恶性患者在术后嗜铬粒蛋白A的检查中发现其阳性表达率分别为85.0%与53.0%,两组比较差异有统计学意义(P〈0.01)。而对应突触素的检查中发现其阳性表达率分别为88.0%与89.0%,两组比较差异无统计学意义(P〉0.05);发生淋巴结转移患者和未发生淋巴结转移患者的嗜铬粒蛋白A阳性表达率分别为47.0%与80.0%,两组比较差异有统计学意义(P〈0.01),对应突触素的检查发现阳性表达率分别为87.0%与87.0%,两组比较差异无统计学意义(P〉0.05)。结论腔镜手术治疗胰腺神经内分泌肿瘤是一种微创、安全的手术方式,患者远期生存率高,采用嗜铬粒蛋白A和突触素对患者的术后水平进行监测,能有效评估疾病的发展与预后,而突触素对患者的预后无任何评估意义。 展开更多
关键词 胰腺神经内分泌肿瘤 嗜铬粒蛋白A 腹腔镜 预后
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部